Microbot Medical Inc. (MBOT )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol MBOT
- Company Microbot Medical Inc.
- Price $2.47
- Changes Percentage 20.32
- Change 0.42
- Day Low $2.13
- Day High $2.58
- Year High $4.67
- Year Low $1.25
- Market Cap $112,399,471
- Price Avg 50 EMA (D) $2.07
- Price Avg 200 EMA (D) $2.58
- Exchange NASDAQ
- Volume 6,016,314
- Average Volume 2,243,201
- Open $2.14
- Previous Close $2.05
- EPS -0.45
- PE -5.48
- Earnings Announcement 2026-02-25 12:00:00
- Shares Outstanding $45,570,432
Company brief: MICROBOT MEDICAL INC. (MBOT )
- Healthcare
- Medical - Instruments & Supplies
- Mr. Harel Gadot
- https://www.microbotmedical.com
- US
- N/A
- 03-25-1992
- US59503A2042
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.